New compstatin variants through two de novo protein design frameworks

Biophysical Journal

Volumn 98, Issue 10, 2010, Pages 2327-2336

  Bellows, M L ^a   Fung, H K ^a   Taylors, M S ^a   Floudas, C A ^a   Lopez De Victoria A ^b   Morikis, D ^b  

^a Princeton University   (United States)

^b University of California Riverside   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77950810925     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2010.01.046     Document Type: Article

References (67)

1. 1. Sahu, A., B. K. Kay, and J. D. Lambris. 1996. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. J. Immunol. 157:884-891. (Pubitemid 26231396)
2. 2. Sahu, A., and J. D. Lambris. 2001. Structure and biology of complement protein C3, a connecting link, between innate and acquired immunity. Immunol. Rev. 180:35-48. (Pubitemid 32472850)
3. 3. Sahu, A., A. M. Soulika, ..., J. D. Lambris. 2000. Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin. J. Immunol. 165:2491-2499. (Pubitemid 30660694)
4. Soulika, A. M., M. M. Khan, ..., J. D. Lambris. 2000. Inhibition of heparin/protamine complex-induced complement activation by Compstatin in baboons. Clin. Immunol. 96:212-221.
5. 5. Nilsson, B., R. Larsson, ..., J. D. Lambris. 1998. Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. Blood. 92:1661-1667. (Pubitemid 28406870)
6. 6. Schmidt, S., G. Haase, ..., H. Peltroche-Llacsahuanga. 2003. Inhibitor of complement, Compstatin, prevents polymer-mediated Mac-1 upregulation of human neutrophils independent of biomaterial type tested. J. Biomed, Mater. Res. A. 66A:491-499. (Pubitemid 37517194)
7. Fiane, A. E., T. E. Mollnes, ..., J. D. Lambris. 1999. Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts. Xenotransplantation. 6:52-65.
8. Mollnes, T. E., O. L. Brekke, ..., J. D. Lambris. 2002. Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood. 100:1869-1877.
9. 9. Klegeris, A., E. A. Singh, and P. L. McGeer. 2002. Effects of C-reactive protein, and pentosan polysulphate on human, complement activation. Immunology. 106:381-388. (Pubitemid 34748132)
10. 10. Sahu, A., D. Morikis, and J. D. Lambris. 2003. Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3. Mol. Immunol. 39:557-566. (Pubitemid 35335834)
11. Klepeis, J. L., C. A. Floudas, ..., J. D. Lambris. 2003. Integrated computational and experimental approach for lead optimization and design of compstatin variants with improved activity. J. Am. Chem. Soc. 125:8422-8423.
12. Klepeis, J. L., C. A. Floudas, ..., J. D. Lambris. 2004. Design of peptide analogs with improved activity using a novel de novo protein design approach. Ind. Eng. Chem. Res. 43:3817-3826.
13. 13. Morikis, D., A. M. Soulika, ..., J. D. Lambris. 2004. Improvement of the anti-C3 activity of compstatin using rational and combinatorial approaches. Biochem. Soc. Trans. 32:28-32. (Pubitemid 38283007)
14. Fung, H. K., M. S. Taylor, and C. A. Floudas. 2007. Novel formulations for the sequence selection problem in de novo protein design with flexible templates. Optimiz.Meth. Softw. 22:51-71.
15. Floudas, C. A., H. K. Fung, ..., L. Zhang. 2007. Overcoming the key challenges in de novo protein design: enhancing computational efficiency and incorporating true backbone flexibility. In Modeling of Biosystems: An Interdisciplinary Approach. R. Mondiani, editor. Springer Verlag, Heidelberg, Germany.
16. .1.6. Fung, H. K., W. J. Welsh, and C. A. Floudas. 2008. Computational de novo peptide and protein design: rigid templates versus flexible templates. Ind. Eng. Chem. Res. 47:993-1001.
17. Floudas, C. A., H. K. Fung, ..., R. Rajgaria. 2006. Advances in protein structure prediction and de novo protein design: a review. Chem. Eng. Sei. 61:966-988.
18. 18. Morikis, D., M. Roy, ..., J. D. Lambris. 2002. The structural basis of compstatin activity examined by structure-function-based design of peptide analogs and NMR. J. Biol. Chem. 277:14942-14953. (Pubitemid 34952569)
19. Soulika, A. M., D. Morikis, ..., J. D. Lambris. 2003. Studies of structure-activity relations of complement inhibitor compstatin. Z Immunol. 171:1881-1890.
20. 20. Mallik, B., M. Katragadda, ..., J. D. Lambris. 2005. Design and NMR characterization of active analogues of compstatin containing non-natural amino acids. J. Med. Chem. 48:274-286. (Pubitemid 40105266)
21. Janssen, B. J. C., E. F. Halff, ..., P. Gros. 2007. Structure of compstatin in complex with, complement component C3c reveals a new mechanism of complement inhibition. J. Biol. Chem, 282:29241-29247.
22. Fung, H. K., C. A. Floudas, ..., D. Morikis. 2008. Toward full-sequence de novo protein design with flexible templates for human β-defensin-2. Biophys. J. 94:584-599.
23. Taylor, M. S., H. K. Fung, ..., C. A. Floudas. 2008. Mutations affecting the oligomerization interface of G-protein-coupled receptors revealed by a novel de novo protein design framework. Biophys. J. 94:2470-2481.
24. Fung, H. K., S. Rao, ..., F. Rendl. 2005. Computational comparison studies of quadratic assignment like formulations for the in silico sequence selection problem in de novo protein design. J. Comb. Optim. 10:41-60.
25. Klepeis, J. L., and C. A. Floudas. 1999. Free energy calculations for peptides via deterministic global optimization. J. Chem. Phys. 110:7491-7512.
26. Klepeis, J. L., C. A. Floudas, ..., J. Lambris. 1999. Predicting peptide structures using NMR data and deterministic global optimization. J. Comput. Chem. 20:1354-1370.
27. Klepeis, J. L., and C. A. Floudas. 2002. Ab initio prediction of helical segments in polypeptides. J.. Comput. Chem. 23:245-266.
28. Klepeis, J. L., and C. A. Floudas. 2003. Prediction, of β-sheet topology and disulfide bridges in polypeptides. J. Comput. Chem. 24:191-208.
29. Klepeis, J. L., and C. A. Floudas. 2003. Ab initio tertiary structure prediction of proteins. J.. Glob. Optim, 25:113-140.
30. Klepeis, J. L., M. T. Pieja, and C. A. Floudas. 2003. A new class of hybrid global optimization algorithms for peptide structure prediction: integrated hybrids. Comput. Phys. Commun. 151:121-140.
31. Klepeis, J. L., M. T. Pieja, and C. A. Floudas. 2003. A new class of hybrid global optimization algorithms for peptide structure prediction: alternating hybrids and applications for Met-encephalin ad melittin. Biophys. J. 84:869-882.
32. Klepeis, J. L., and C. A. Floudas. 2003. ASTRO-FOLD: a combinatorial and global optimization framework for Ab initio prediction of threedimensional structures of proteins from the amino acid sequence. Biophys. J. 85:2119-2146.
33. Klepeis, J. L., Y. Wei, ..., C. A. Floudas. 2005. Ab initio prediction of the three-dimensional structure of a de novo designed protein: a doubleblind case study. Proteins. 58:560-570.
34. McAllister, S. R., B. E. Mickus, ..., C A. Floudas. 2006. Novel approach for a-helical topology prediction in globular proteins: generation of interhelical restraints. Proteins. 65:930-952.
35. Adjiman, C. S., S. Dallwig, and C A. Floudas. 1998. A global, optimization, method, α BB, for general twice-differentiable constrained NLPs. I. Theoretical advances. Comput. Chem. Eng. 22:1137-1158.
36. Androulakis, I., C. Maranas, and C. A. Floudas. 1995. Alpha BB: a global optimization method for general constrained nonconvex problems. J. Glob. Optim. 7:337-363.
37. Adjiman, C., I. Androulakis, and C. A. Floudas. 1998. A global, optimization, method, α BB, for general twice-differentiable constrained NLPs. II. Implementation and computational results. Comput. Chem. Eng. 22;1159-1179.
38. 38. Androulakis, I., C. Maranas, and C. A. Floudas. 1997. Prediction of oligopeptide conformations via deterministic global optimization. J. Glob. Optim. 11:1-34. (Pubitemid 127502318)
39. Floudas, C. A., and P. M. Pardalos. 1995. State-of-the-art in global optimization-computational methods and applications-preface. J. Glob. Optim. 7:113.
40. Esposito, W. R., and C. A. Floudas. 1998. Global, optimization in parameter estimation, of nonlinear algebraic models via the error-invariables approach. Ind. Eng. Chem. Res. 37:1841-1858.
41. Esposito, W. R., and C. A. Floudas. 2000. Deterministic global optimization, in nonlinear optimal, control problems. J. Glob. Optim. 17:97-126.
42. 42. Rajgaria, R., S. R. McAllister, and C. A. Floudas. 2008. Distancedependent centroid-to-centroid force fields using high-resolution decoys. Proteins. 70:950-970. (Pubitemid 351161953)
43. 43. Güntert, P., C Mumenthaler, and K. Wüthrich. 1997. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J. Mol. Biol. 273:283-298. (Pubitemid 27460230)
44. Guntert, P. 2004. Automated NMR structure calculation with CYANA. J. Mol. Biol. 278:353-378.
45. Ponder, J. 1998. TINKER, Software Tools for Molecular Design. Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO.
46. Floudas, C. A., and H. K. Fung. 2007. Mathematical modeling and optimization methods for de novo protein design. In Systems Biology, Vol.II I. Rigoutsos and G. Stephanopoulos, editors. Oxford University Press, Oxford, UK.
47. 47. Rohl, C. A., C. E. M. Strauss, ..., D. Baker. 2004. Protein structure prediction, using ROSETTA. Methods Enzymol. 383:66-93. (Pubitemid 38401787)
48. Gray, J. J., S. Moughon, ..., D. Baker. 2003. Protein-protein docking with simultaneous optimization of rigid-body displacement and sidechain, conformations. J. Mol. Biol. 331:281-299.
49. Kuhlman, B., and D. Baker. 2000. Native protein sequences are close to optimal for their structures. Proc Natl. Acad. Sci. USA. 97:10383-10388.
50. Lilien, R. H., B. W. Stevens, ..., B. R. Donald. 2005. A novel ensemblebased scoring and search algorithm for protein redesign and its application to modify the substrate specificity of the gramicidin synthetase A phenylalanine adenylation enzyme. J. Comput. Biol. 12:740-761.
51. α RMSD structure predictions on two small proteins, HP-36 and S15. J. Am. Chem. Soc. 123:1040-1046.
52. 52. Rohl, C. A., and D. Baker. 2002. De novo determination of protein backbone structure from residual dipolar couplings using ROSETTA. J.Am. Chem. Soc. 124:2723-2729. (Pubitemid 34251782)
53. DiMaggio, P. A., S. R. McAllister, ..., H. A. Rabitz. 2008. Biclustering via optimal re-ordering of data matrices in systems biology: rigorous methods and comparative studies. BMC Bioinformatics. 9:458.
54. Reference deleted in proof.
55. Daily, M. D., D. Masica, ...., J. J. Gray. 2005. CAPRI rounds 3-5 reveal promising successes and future challenges for RosettaDock. Proteins. 60:181-186.
56. Gray, J. J., S. E. Moughon, ..., D. Baker. 2003. Protein-protein docking predictions for the CAPRI experiment. Proteins. 52:118-122.
57. 57. Lazaridis, T., and M. Karplus. 1999. Effective energy function for proteins in solution. Proteins: Struct. Funct. Gen. 35:133-152. (Pubitemid 29165128)
58. Barlow, R. B., S. M. Bond, ..., D. S. McQueen. 1997. Antagonist inhibition curves and the measurement of dissociation constants. Br. J. Pharmacol. 120:13-18.
59. Boehr, D. D., and P. E. Wright. 2008. Biochemistry. How do proteins interact? Science. 320:1429-1430.
60. Lange, O. F., N.-A. Lakomek, ...,B. L. de Groot. 2008. Recognition dynamics up to microseconds revealed from an RDC-derived ubiquitin. ensemble in solution. Science. 320:1471-1475.
61. 61. Morikis, D., N. Assa-Munt, ...,J. D. Lambris. 1998. Solution structure of Compstatin, a potent complement inhibitor. Protein Sci. 7:619-627. (Pubitemid 28130884)
62. 62. Merutka, G., D. Morikis, ..., P. Wright. 1993. NMR evidence for multiple conformations in a highly helical model peptide. Biochemistry. 32:13089-13097. (Pubitemid 24005916)
63. 63. Morikis, D., and J. D. Lambris. 2002. Structural aspects and design of low-molecular-mass complement inhibitors. Biochem. Soc. Trans. 30:1026-1036. (Pubitemid 36002400)
64. 64. Mallik, B., J. D. Lambris, and D. Morikis. 2003. Conformational interconversion in compstatin probed with molecular dynamics simulations. Proteins. 53:130-141. (Pubitemid 37059551)
65. 65. Mallik, B., and D. Morikis. 2005. Development of a quasi-dynamic pharmacophore model for anti-complement peptide analogues. J. Am. Chem. Soc. 127:10967-10976. (Pubitemid 41129872)
66. 66. Tamamis, P., S. S. Skourtis, ..., G. Archontis. 2007. Conformational analysis of compstatin analogues with molecular dynamics simulations in explicit water. J. Mol. Graph. Model. 26:571-580. (Pubitemid 47337196)
67. Zhang, L., and D. Morikis. 2007. Solution structure of a bent α-helix. Biochemistry. 46:12959-12967.